Northwestern Medicine investigators have developed first-of-its-kind eyedrops that use synthetic nanoparticles to help the ...

Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...

Scientists have developed eyedrops that can reverse inflammation and repair corneal stem cell damage in a mouse model of ...

First Quarter 2025 Financial Results: G&A Expenses: For the quarter ended March 31, 2025, general and administrative (G&A) expenses were $4.6 million, compared to $5.4 million for the same period in ...

In a recent, cross-institutional study partially funded by the National Institutes of Health, researchers report that healthy ...

From dehydration and UTIs to kidney stones and medication effects, discover the common reasons behind cloudy urine and when ...

Phase 2 ARCHER Data Support Therapeutic Potential for ANX007 to Preserve Vision in Patients who have Dry Age-related Macular Degeneration (AMD) with Geographic Atrophy (GA) Phase 3 ARCHER II Trial ...